Clinical Trial Update: A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR) [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing prednisolone with SPI-62 versus placebo in polymyalgia rheumatica has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Prednisolone (Prednisolone)
• SPI-62

Snippet

Sponsor: Sparrow Pharmaceuticals | Conditions: Polymyalgia Rheumatica | Phase 2 | Status: COMPLETED